M&A Deal Summary |
|
|---|---|
| Date | 2021-09-30 |
| Target | Interiors Group |
| Sector | Retail |
| Buyer(s) | Pencarrow Private Equity |
| Sellers(s) | Allegro Funds |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1993 |
| PE ASSETS | 692M NZD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Pencarrow Private Equity is a private equity firm focused on investing in New Zealand owned and operated businesses. Pencarrow looks to support management buyouts, management buy-ins, and provide expansion capital for companies operating in a variety of sectors. Areas of interest include building materials, distribution, manufacturing, consumer products, business services, and capital equipment. Target companies are typically valued between NZ$20 and $150 million where the Firm can commit $10 to $30 million in equity capital. Pencarrow Private Equity was formed in 1993 and is based in Wellington, New Zealand.
| DEAL STATS | # |
|---|---|
| Overall | 21 of 24 |
| Sector: Retail M&A | 2 of 2 |
| Type: Secondary Buyout M&A Deals | 1 of 1 |
| Country: New Zealand M&A | 20 of 23 |
| Year: 2021 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-11 |
Seequent
Canterbury, New Zealand Seequent is a provider in the visualization and interpretation of geological data for applications in the mining, minerals, energy, civil and environmental industries. Seequent provides software and consultancy solutions and has received wide acclaim for its flagship product, Leapfrog. Seequent was founded in 2003 and is based in Canterbury, New Zeland. |
Sell | $1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-26 |
Pacific Clinical Research Network
Auckland, New Zealand Pacific Clinical Research Network (PCRN) comprises of two clinical trials businesses (Lakeland Clinical Trials Group and Southern Clinical Trials Group) that perform the administration of new pharmaceuticals and medical devices under controlled conditions as part of a clinical trial, with a focus on phase 1b to 4 clinical trials. PCRN operates two sites directly, in Rotorua and Christchurch, and has a separate franchise network of ten additional sites across New Zealand. Pacific Clinical Research Network is based in Auckland, New Zealand. |
Buy | - |
| Category | Distressed Investor |
|---|---|
| Founded | 2004 |
| PE ASSETS | 4.8B AUD |
| Size | Large |
| Type | Sector Agnostic |
Allegro Funds is an independent private equity firm focused on mid-sized investment opportunities in Australia and New Zealand. The Firm will consider investing in businesses needing capital for growth, management buyouts, as well as more complex turnarounds and restructurings. Allegro's target investment size is A$10 to A$100 million in transactions valued up to A$300 million. Allegro is a generalist investor, however the Firm will not invest in property development, agriculture, or mining/exploration. Allegro Funds was formed in 2004 and is based in Sydney.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 16 |
| Sector: Retail M&A | 3 of 3 |
| Type: Secondary Buyout M&A Deals | 3 of 4 |
| Country: New Zealand M&A | 1 of 1 |
| Year: 2021 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-26 |
Best & Less Group
Sydney, Australia Best & Less Group is made up of iconic retail brands that include Best & Less and Postie (NZ). The two brands together operate over 250 stores across Australia and New Zealand and employ over 4,000 employees. Best & Less Group is based in Sydney, Australia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-15 |
Journey Beyond
Adelaide, Australia Journey Beyond is an experiential tourism group that is privileged to own and operate 13 brands spanning the country, connecting guests to the land, and to each other. Journey Beyond was founded in 2016 and is based in Adelaide, Australia. |
Sell | - |
